| Filed | Form | Items | Signal | Score | Summary | Link |
|---|---|---|---|---|---|---|
| 2026-06-09 17:20 | 8-K | ["5.02", "9.01"] | material agreement | 0.72 | Adoption of Change in Control severance plan with enhanced benefits suggests M&A preparation or ongoing strategic transaction discussions. | SEC · detail |
| 2026-06-09 17:19 | 8-K | ["5.07", "9.01"] | other | 0.05 | Routine annual stockholder meeting voting results; no M&A signals present. | SEC · detail |
| 2026-06-03 09:04 | 8-K | ["8.01", "9.01"] | other | 0.05 | Patent settlement announcement for SUNOSI; no M&A-related content detected. | SEC · detail |
| 2026-05-04 07:07 | 8-K | ["2.02", "8.01", "9.01"] | other | 0.05 | Routine Q1 2026 earnings announcement and corporate presentation update; no M&A signals. | SEC · detail |
| 2026-04-30 17:19 | 8-K | ["8.01", "9.01"] | other | 0.02 | FDA approval announcement for AUVELITY; no M&A or strategic transaction signals. | SEC · detail |